Skip to main content

On-Demand webinar: Navigating the future of 340B

Expert insights you can’t miss

The 340B Drug Pricing Program is at a crossroads, facing increased scrutiny, manufacturer restrictions, and ongoing legal battles. In this must-watch webinar, industry experts Ted Slafsky (340B Report), Emily Cook (McDermott, Will & Emery), and Nicole Shoquist (JPS Health Network) break down the biggest challenges ahead and what covered entities need to prepare for in 2025 and beyond.

A glimpse of what you’ll learn:

Fill out the form below to watch the webinar now.

Name(Required)
This field is for validation purposes and should be left unchanged.

Maxor
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.